Cord tissue membrane and cord lining stem cells use a patented processing technique. Outside of the above preferred partners, cells obtained by other means or from other service providers cannot be guaranteed for future use which may include stem cell therapy or stem cell treatments. Moreover, Epithelial Stem Cells in their earliest Passage and in large quantities can only be harvested from very limited sources and to date, the cord tissue membrane looks to have the largest yield.

From a single umbilical cord, up to 6 billion Mesenchymal Stem Cells and 6 billion Epithelial Stem Cells can be harvested in its earliest Passage, which is a very important consideration in the regenerative and therapeutic application requirement.

Multiple regenerative and therapeutic applications are currently being studied and cord tissue membrane and cord lining stem cells should be a tissue of choice to be stored at birth together with cord blood. Information on cord lining stem cell uses can be found on the various pages inside http://vwwv.globalcordregistry.com/